Hamid, O., K. Lewis, A. Weise, M. McKean, K. P. Papadopoulos, J. Crown, T. M. Kim, N. J. Lakhani, J. Kaczmar, R. Kudchadkar, A. Spira, G. Rabinowits, K. Kim, R. Carvajal, S. Williamson, E. Ioffe, S. Chen, J. Mani, V. Jankovic, L. Brennan, G. Kroog, T. Sims, I. Lowy, and G. Gullo. “Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma: Expansion Cohort Analysis”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s179, doi:10.25251/skin.7.supp.179.